Abvc Biopharma, Inc. (ABVC) SEC Filings — 2025
19 SEC filings for Abvc Biopharma, Inc. (ABVC) in 2025.
Filings
- ABVC BioPharma's Assets Soar 180% Amidst Widening Losses — 10-Q · Nov 3, 2025
- ABVC Biopharma Announces Board and Executive Changes — 8-K · Oct 30, 2025
- ABVC Biopharma Files Amendment on Accountant Change — 8-K/A · Sep 12, 2025
- ABVC Biopharma Files 8-K on Financials — 8-K · Aug 14, 2025
- ABVC BioPharma's Assets Soar 115% Amidst Continued Losses — 10-Q · Aug 13, 2025
- ABVC Biopharma Files 8-K/A Amendment — 8-K/A · Jul 18, 2025
- ABVC Biopharma Files 8-K for Shareholder Votes & Exhibits — 8-K · Jun 4, 2025
- ABVC Biopharma Files 8-K/A Amendment — 8-K/A · May 30, 2025
- ABVC Biopharma Files Definitive Proxy Statement — DEF 14A · May 16, 2025
- ABVC Biopharma Files Amendment on Delisting Concerns — 8-K/A · May 14, 2025
- ABVC Biopharma Files 8-K/A Amendment on Listing Status — 8-K/A · May 6, 2025
- ABVC BioPharma Amends Financial Statement Reliance Filing — 8-K/A · May 2, 2025
- ABVC Biopharma Files 8-K on Operations and Financials — 8-K · May 1, 2025
- ABVC BioPharma Files Q1 2025 10-Q Report — 10-Q · Apr 30, 2025
- ABVC BioPharma Files 8-K Amendment — 8-K/A · Apr 16, 2025
- ABVC BioPharma Files 2024 Annual Report — 10-K · Apr 15, 2025
- ABVC Biopharma Shuffles Leadership — 8-K · Mar 7, 2025
- ABVC Biopharma Files 8-K/A Amendment on Listing Rule Compliance — 8-K/A · Jan 13, 2025
- ABVC Biopharma Files 8-K: Material Agreement & Equity Sales — 8-K · Jan 6, 2025